Mgen...... A buyout very soon Biotech's Next Billion Dollar Buyout Today, I'm also recommending you enter a position in Miragen Therapeutics, Inc. (MGEN), a company that I first profiled for Takeover Alert subscribers. I'll get into the details in a moment. But here's why the situation is so urgent The company reported strong Phase 1 interim data that went virtually unnoticed by the market. Why? Well, I'm convinced it's because the company came to market via a reverse merger. That means it didn't pop up immediately on everyone's radar like it would have during a traditional IPO. Here's the thing Miragen did come to market with "establishment" investors well-heeled and top-performing institutions, including Atlas Venture, Brace Pharma Capital, Boulder Ventures, and MRL Ventures. So it's a completely validated and legitimate opportunity. Otherwise these institutions wouldn't be associated with it, nor would they have jumped at the chance to provide millions in financing upon the closing of the reverse merger. In short, based on the newest data, the company should be trading 75% higher than current prices. In a takeover, the company could easily be worth 300% to 400% more than current prices. So don't delay! Action to take: Buy Miragen Therapeutics, Inc. (MGEN) at market. I'll be in touch again tomorrow with more details behind this opportunity. Ahead of the tape,